Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia
Authors:
- 19 June 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 123 (25) , 3864-3872
Abstract
Key Points: Modified ActRIIB ligand trap promotes terminal erythroid differentiation and mitigates ineffective erythropoiesis in murine β-thalassemia. This agent reduces anemia, α-globin aggregates, hemolysis, and disease complications such as iron overload, splenomegaly, and bone defects.Keywords
This publication has 46 references indexed in Scilit:
- An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe−/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermediaBlood, 2013
- β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolismBlood, 2011
- Stress erythropoiesis: new signals and new stress progenitor cellsCurrent Opinion in Hematology, 2011
- Hepcidin and Disorders of Iron MetabolismAnnual Review of Medicine, 2011
- Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic miceJournal of Clinical Investigation, 2010
- Protein Quality Control During Erythropoiesis and Hemoglobin SynthesisHematology/Oncology Clinics of North America, 2010
- Complex and Context Dependent Regulation of Hematopoiesis by TGF‐β Superfamily SignalingAnnals of the New York Academy of Sciences, 2009
- Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cellsBlood, 2009
- Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemiaBlood, 2008
- What is Ineffective Erythropoiesis in Myelodysplastic Syndromes?Leukemia & Lymphoma, 1995